Tyra Biosciences (TYRA) Revenue & Revenue Breakdown
Tyra Biosciences Revenue Highlights
00
Tyra Biosciences Revenue by Period
Tyra Biosciences Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
Tyra Biosciences generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Tyra Biosciences Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $496.00K | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $502.00K | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
Tyra Biosciences generated - in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
Tyra Biosciences Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| MRVI | Maravai LifeSciences | $259.19M | $41.63M |
| DAWN | Day One Biopharmaceuticals | $131.16M | $39.80M |
| GERN | Geron | $76.50M | $47.23M |
| KURA | Kura Oncology | $53.88M | $20.75M |
| EYPT | EyePoint Pharmaceuticals | $43.27M | $966.00K |
| NBTX | Nanobiotix | $30.06M | $30.06M |
| PRME | Prime Medicine | $2.98M | $1.23M |
| PROK | ProKidney | $76.00K | $217.00K |
| RZLT | Rezolute | - | - |
| SVRA | Savara | - | - |
| TYRA | Tyra Biosciences | - | - |